Process development
Process development
Boosting Biopharmaceutical Manufacturing with Real-Time Control
📰 Optimizing Critical Quality Attributes during Processing explores how a cyber-physical system and digital twin can improve biopharmaceutical manufacturing. 💊🔬🚀
WHO Launches Biomanufacturing Training to Boost Global Vaccine Production
🌍 WHO launches Biomanufacturing Workforce Training Initiative to improve bioproduction in LMICs. 🏭💪🔬 Enhancing local vaccine production and building capacity.
Groundbreaking Cancer Drug Shows Remarkable Results
Exciting news! Vidac Pharma reports preclinical success for cancer drug VDA-1275, showing increased efficacy and immune response. 🚀💊🔬
Unlocking Patent Protection Secrets for Biosimilars
🔬 Recent developments in biologic therapeutics have created challenges in scaling up production for new indications. 💡 ⚙️ Advances in QTL-enabled recombinant protein projects offer opportunities for additional patent protection. 💼 📈 Upgrading manufacturing processes and optimizing production can reduce costs and achieve market dominance. 💰 🚫 Avoid risks of outdated manufacturing approaches and ensure feasibility and investor interest in biosimilar projects. 💪 ✨ QTL technology provides tailored solutions and extended patent protection, making it a valuable tool in the market. ✅
Revolutionizing Biomanufacturing: Faster Cheaper and More Efficient
🧪 Quick production of therapeutics and vaccines using a disease-agnostic platform approach. 📊 Improved mRNA yields in just two hours. 🖥️ Real-time process monitoring and control. 💉 Billions of vaccine doses produced using a platform process. 🧫 Efficient and cost-effective allogeneic cell therapies. 🌐 Scalable, monitored, and controlled manufacturing of advanced therapies and vaccines. 💡 Future perspective: reducing costs and manufacturing risk with platform-based iPSC production.
Discover the Future of Therapies: Say Goodbye to Plant Extracts!
🌱 Transitioning from Plant Extracts: Many biotech and pharmaceutical companies still rely on nature for therapies. 🌿 Vinblastine, a plant-based chemotherapy, can be created through bioprocessing and chemical synthesis. 💡 Bioprocessing offers a sustainable alternative to plant-sourced routes in producing chemotherapies. 🌍 Opportunities to turn from plant collecting to bioprocessing exist globally, with many plants used for medicinal purposes. 📚 This is just the beginning of finding new ways to bioprocess therapies instead of extracting them from plants.
Bioplastics Production to Skyrocket: 4x Increase Expected!
🌍 Global production capacity for bioplastics is expected to quadruple by 2028, reaching around 7.5 million tonnes per year. 📈 This increase is driven by the growing demand for sustainable materials and advancements in biopolymer technology. ♻️ The proportion of biodegradable plastics in the total volume of bioplastics is also set to increase. The European Bioplastics association is calling for policy support to accelerate the growth of the bioplastics industry. 🌱📢
Revolutionizing Biopharmaceutical Market: ICH Q5A R2’s Game-Changing Impact
📢 Discover the Impact of ICH Q5A R2 on the Biopharmaceutical Market! ⚙️ Explore development, processing, manufacturing, and more! 🌍
Revolutionary Low-Cost Alternative to E coli in Synthetic Biology
💡 Cornell University creates low-cost and scalable platform for synthetic biology using engineered Vibrio natriegens, competing with E. coli. 🧬🔬
Revolutionary Gene Therapy for Heart Failure: Promising Results!
💉 Bayer's AskBio unit begins Phase II testing of gene therapy AB-1002 for heart failure patients. Promising results!
